Troyen Brennan - Oct 26, 2021 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Chief Medical Officer
Signature
/s/ Troyen Brennan
Stock symbol
CVS
Transactions as of
Oct 26, 2021
Transactions value $
-$2,903,956
Form type
4
Date filed
10/28/2021, 04:34 PM
Previous filing
Sep 7, 2021
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $4.38M +80.8K +57.63% $54.19 221K Oct 26, 2021 Direct
transaction CVS Common Stock Sale -$172K -1.96K -0.88% $88.00 219K Oct 26, 2021 Direct
transaction CVS Common Stock Sale -$7.11M -80.8K -36.89% $88.00 138K Oct 26, 2021 Direct F1
holding CVS Common Stock (restricted) 4.81K Oct 26, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -80.8K -50% $0.00 80.8K Oct 26, 2021 Common Stock 80.8K $54.19 Direct F2
holding CVS Stock Option 47.9K Oct 26, 2021 Common Stock 47.9K $102.26 Direct F3
holding CVS Stock Option 53.8K Oct 26, 2021 Common Stock 53.8K $104.82 Direct F4
holding CVS Stock Option 75.1K Oct 26, 2021 Common Stock 75.1K $78.05 Direct F5
holding CVS Stock Option 21.9K Oct 26, 2021 Common Stock 21.9K $62.21 Direct F6
holding CVS Stock Option 113K Oct 26, 2021 Common Stock 113K $58.34 Direct F7, F8
holding CVS Stock Option 99.3K Oct 26, 2021 Common Stock 99.3K $74.30 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F5 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.